Henry M. Sondheimer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Henry M. Sondheimer has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Eric A.F Simoes
Univ. of Colorado School of Medicine-The Children's Hospital, Denver, CO.
2 shared publicationsJessie R Groothuis
Dept. of Peds, Univ. of Colorado School of Medicine, Denver
2 shared publicationsA.R. Seay
Division of Child Neurology, The Children’s Hospital, University of Colorado Health Sciences Center, Denver, USA
1 shared publicationAndrew A Kramer
Univ. of Colorado School of Medicine-The Children's Hospital, Denver, CO.
1 shared publicationB. K. Gleason
Section of Cardiology, Department of Pediatrics, The Children’s Hospital/University of Colorado Health Sciences Center, 1056 E, 19th Avenue, Denver, CO 80218, USA
1 shared publicationB. Pietra
Section of Cardiology, Department of Pediatrics, The Children’s Hospital/University of Colorado Health Sciences Center, 1056 E, 19th Avenue, Denver, CO 80218, USA
1 shared publication
Latest Publications
- 1 February 2006
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 16 (S3) , 131-135
Current management of ventricular septal defect
At this time, the current practice for treatment of patients with isolated ventricular septal defect is infrequently studied. With this in mind, it was our intent to assess the current management of ventricular septal defect at a single center, The Children's Hospital, Denver. We reviewed the practice at this institution to determine if there is an evidence base for when or if a patient with an isolated ventricular septal defect requires surgical repair. With approval from the Colorado Multiple Institutional Review Board (protocol # 06-0097), we reviewed the data on patients with isolated ventricular septal defect seen during the calendar years of 2004 and 2005, determining the state of the patients, and the level of intervention through December 31, 2005.
- 1 February 2006
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 16 (S3) , 131-135
Current management of ventricular septal defect
At this time, the current practice for treatment of patients with isolated ventricular septal defect is infrequently studied. With this in mind, it was our intent to assess the current management of ventricular septal defect at a single center, The Children's Hospital, Denver. We reviewed the practice at this institution to determine if there is an evidence base for when or if a patient with an isolated ventricular septal defect requires surgical repair. With approval from the Colorado Multiple Institutional Review Board (protocol # 06-0097), we reviewed the data on patients with isolated ventricular septal defect seen during the calendar years of 2004 and 2005, determining the state of the patients, and the level of intervention through December 31, 2005.
- 5 November 2004
- Published by Springer Nature in Pediatric Cardiology
- Vol. 26 (1) , 34-38
Profound Hypothermia with Alpha-Stat pH Management During Open-Heart Surgery Is Associated with Choreoathetosis
A retrospective chart review was conducted to examine risk factors associated with the occurrence of choreoathetosis, a rare but significant complication of open-heart surgery in children. Ten children were identified as having developed choreoathetosis after cardiac surgery. Their charts were reviewed and compared with 33 age- and diagnosis-matched controls who underwent open-heart surgery during the same time period. Children with choreoathetosis reached lower rectal and esophageal temperatures (p = 0.0018 for both) and spent a greater portion of total bypass time at lower rectal and esophageal temperatures (p < 0.001 for both). Duration of cooling below 20°C esophageal temperature and PaCO2 at the end of the cooling period were significant predictors of choreoathetosis (p = 0.023 and p = 0.0497, respectively) in a logistic regression model, and a greater fraction of choreoathetosis patients had prior developmental delays (p = 0.017). No difference was found in the age at surgery, duration of bypass, aortic cross-clamp time, arterial pH, PaCO2 or mean arterial pressure. The combination of extended exposure to profound hypothermia and alpha-stat pH management strategy and preexisting developmental delay are associated with the development of choreoathetosis following open-heart surgery 61 in children.
- 5 November 2004
- Published by Springer Nature in Pediatric Cardiology
- Vol. 26 (1) , 34-38
Profound Hypothermia with Alpha-Stat pH Management During Open-Heart Surgery Is Associated with Choreoathetosis
A retrospective chart review was conducted to examine risk factors associated with the occurrence of choreoathetosis, a rare but significant complication of open-heart surgery in children. Ten children were identified as having developed choreoathetosis after cardiac surgery. Their charts were reviewed and compared with 33 age- and diagnosis-matched controls who underwent open-heart surgery during the same time period. Children with choreoathetosis reached lower rectal and esophageal temperatures (p = 0.0018 for both) and spent a greater portion of total bypass time at lower rectal and esophageal temperatures (p < 0.001 for both). Duration of cooling below 20°C esophageal temperature and PaCO2 at the end of the cooling period were significant predictors of choreoathetosis (p = 0.023 and p = 0.0497, respectively) in a logistic regression model, and a greater fraction of choreoathetosis patients had prior developmental delays (p = 0.017). No difference was found in the age at surgery, duration of bypass, aortic cross-clamp time, arterial pH, PaCO2 or mean arterial pressure. The combination of extended exposure to profound hypothermia and alpha-stat pH management strategy and preexisting developmental delay are associated with the development of choreoathetosis following open-heart surgery 61 in children.
- 1 December 2003
- Published by Springer Nature in Pediatric Cardiology
- Vol. 24 (6) , 538-543
Improved Pretransplant Management of Infants with Hypoplastic Left Heart Syndrome Enables Discharge to Home while Waiting for Transplantation
For infants whose families select primary transplantation for hypoplastic left heart syndrome (HLHS), the waiting time averages 3 months. Given the relative shortage of organs, the morbidity and mortality of these patients have been high. Therefore, pretransplant management is critical to improve the number of patients who survive to transplantation. This series shows our evolving management for these children, with an emphasis on nonintensive care. Fifty-two infants with HLHS were listed for primary transplantation at our institution during a 6-year period. The management was aimed at manipulating the pulmonary and systemic blood flows by low-dose continuous infusion of prostaglandin E1 (PGE1), early use of inhaled nitrogen, delayed opening of the atrial septum, and discharge to home with PGE1 infusion for continuing care when the child was on room air and growing. Almost all of the children (46/ 52) required nitrogen therapy with initial FiO2 of 0.16-0.17. Patients were weaned off nitrogen by 5 to 6 weeks of age. One fourth of the children needed atrial septal opening, typically at 2 or 3 months of age. Seventeen (32.7%) of the infants were able to spend at least some of their waiting time at home. Forty-five of the 52 children (86.5%) survived to receipt of a donor heart. Newborns with HLHS whose families select primary transplantation as their surgical option can be managed with a minimally invasive approach until receipt of a donor heart with an improvement in mortality rate.
- 1 December 2003
- Published by Springer Nature in Pediatric Cardiology
- Vol. 24 (6) , 538-543
Improved Pretransplant Management of Infants with Hypoplastic Left Heart Syndrome Enables Discharge to Home while Waiting for Transplantation
For infants whose families select primary transplantation for hypoplastic left heart syndrome (HLHS), the waiting time averages 3 months. Given the relative shortage of organs, the morbidity and mortality of these patients have been high. Therefore, pretransplant management is critical to improve the number of patients who survive to transplantation. This series shows our evolving management for these children, with an emphasis on nonintensive care. Fifty-two infants with HLHS were listed for primary transplantation at our institution during a 6-year period. The management was aimed at manipulating the pulmonary and systemic blood flows by low-dose continuous infusion of prostaglandin E1 (PGE1), early use of inhaled nitrogen, delayed opening of the atrial septum, and discharge to home with PGE1 infusion for continuing care when the child was on room air and growing. Almost all of the children (46/ 52) required nitrogen therapy with initial FiO2 of 0.16-0.17. Patients were weaned off nitrogen by 5 to 6 weeks of age. One fourth of the children needed atrial septal opening, typically at 2 or 3 months of age. Seventeen (32.7%) of the infants were able to spend at least some of their waiting time at home. Forty-five of the 52 children (86.5%) survived to receipt of a donor heart. Newborns with HLHS whose families select primary transplantation as their surgical option can be managed with a minimally invasive approach until receipt of a donor heart with an improvement in mortality rate.
- 1 April 1996
- Published by Springer Nature in Pediatric Research
- Vol. 39 (4) , 38
PROSPECTIVE DEVELOPMENT OF A CARDIAC SCORING SYSTEM TO PREDICT THE SEVERITY AND OUTCOME OF CONGENITAL HEART DISEASE (CHD). 211
- 1 April 1996
- Published by Springer Nature in Pediatric Research
- Vol. 39 (4) , 38
PROSPECTIVE DEVELOPMENT OF A CARDIAC SCORING SYSTEM TO PREDICT THE SEVERITY AND OUTCOME OF CONGENITAL HEART DISEASE (CHD). 211
- 1 April 1996
- Published by Springer Nature in Pediatric Research
- Vol. 39 (4) , 113
RESPIRATORY SYNCYTIAL VIRUS IMMUNOGLOBULIN AS PROPHYLAXIS AGAINST RESPIRATORY SYNCYTIAL VIRUS IN CHILDREN WITH CONGENITAL HEART DISEASE. • 662
- 1 April 1996
- Published by Springer Nature in Pediatric Research
- Vol. 39 (4) , 113
RESPIRATORY SYNCYTIAL VIRUS IMMUNOGLOBULIN AS PROPHYLAXIS AGAINST RESPIRATORY SYNCYTIAL VIRUS IN CHILDREN WITH CONGENITAL HEART DISEASE. • 662